drugset / Trial / NCT01389908
A Follow up Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective Disorder
NaSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to assess the long-term efficacy of Olanzapine Pamoate (OP) Depot in patients diagnosed with schizophrenia or schizoaffective disorder.
Timeline
- Start
- 2011-06
- Primary completion
- 2014-07
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olanzapine | Small molecule | 280 mg | Intramuscular |
| Subject | Olanzapine | Small molecule | 405 mg | Intramuscular |